Platelet-derived growth factor (PDGF) is believed to be a critical mediator of vascular smooth muscle cell (SMC) proliferation. Because insulin-like growth factor (IGF) I (IGF-I) functions as a progression factor for the mitogenic effects of PDGF, we hypothesized that IGF-I gene expression and the production of IGF binding proteins (IGFBPs) by cultured rat aortic SMCs might be regulated by one or more of the three isoforms of PDGF: PDGF-AA, -BB, and -AB. IGF-I gene expression was highly dependent on cell density: IGF-I mRNA transcripts decreased markedly as a function of cell confluence. IGF-I mRNA content was inhibited to a similar degree by PDGF-AA, -BB, and -AB through a mechanism requiring protein synthesis. The inhibition was readily apparent at 4 hours, reaching approximately 25% of control levels after 24 hours. Radioimmunoassayable IGF-I was only barely detectable in SMC-conditioned serum-free medium and not significantly modulated by PDGF. Western ligand blot revealed that vascular SMCs release 30-kd and 24-kd IGFBP into serum-free conditioned medium. PDGF isoforms did not significantly alter release of the 30-kd IGFBP but evoked a fivefold to sixfold increase in the 24-kd IGFBP. The 24-kd IGFBP was found to comigrate with IGFBP-4, a recently identified binding protein that inhibits IGF action. The 30-kd protein was not merely a glycosylated form of IGFBP-4, because it was not sensitive to
V ascular smooth muscle cell (SMC) proliferation is the histological hallmark of a variety of diseases of the blood vessel, including the formation of the atherosclerotic plaque and the response to vascular injury after balloon angioplasty. The cell signals and molecular events that drive this process are only partially understood. Platelet-derived growth factor (PDGF), abundantly present in platelet alpha granules, is a known SMC mitogen.',2 PDGF is a dimer of two polypeptide chains (A and B) that combine into either a heterodimer (AB) or homodimers (AA and BB). The three isoforms of PDGF bind with different affinities to two distinct cell surface receptors for PDGF, denoted types a and /.3 The absolute and relative amounts of the various PDGF isoforms in serum from different species and in medium conditioned by cultured cells vary largely.4.5 Human platelets contain PDGF-AA and -AB.5 PDGF-BB predominates in animal sera (other than human), in medium conditioned by cultured endothelial cells, and in macrophages infiltrating the atherosclerotic plaque.6 In contrast, vascular SMCs are reported to secrete predominantly PDGF-AA.7,8 Depending on the availability of the various PDGF isoforms and the distribution of the receptor subtypes in the target tissues, it is reasonable to assume that different cellular and biochemical responses to PDGF may ensue.
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PDGF stimulation of mesenchymal cell replication requires the presence of insulin-like growth factor (IGF) I (IGF-I), which acts as a progression factor for cell replication.9 Indeed, IGF-I and PDGF have synergistic effects on the growth of porcine aortic SMCs. 10 IGF-I is a ubiquitously expressed polypeptide growth factor with structural similarity to proinsulin.1" Several investigators have reported expression of IGF-I by vascular SMCs and postulated a paracrine role for this peptide on SMC growth. '2-'4 There are conflicting data regarding the effects of PDGF on IGF-I gene expression by mesenchymal cells. Clemmons and col-leagues12'15 have shown that purified PDGF stimulates radioimmunoassayable IGF-I secretion in human fibro-blasts15 and in porcine vascular SMCs.12 In contrast, PDGF has been reported to either induce14 or de-crease16 IGF-I mRNA abundance of SMCs. We have recently observed that IGF-I mRNA content is markedly induced in the rat aorta by balloon endothelial denudation.13 A candidate signal for this event is PDGF, because it is released from aggregating platelets and also produced by cells within the vessel wall. Thus, understanding the nature of interactions between PDGF and IGF-I may be significant in clarifying the events occurring after vascular injury.
The metabolic and proliferative actions of IGFs are modulated by different types of IGF binding proteins (IGFBPs), which transport IGFs in blood, regulate access to their specific receptors, and control the entry of IGFs into cells. 17 Depending on their structure and on the cell type, IGFBPs can either inhibit or augment the effects of IGFs. A growing number of IGFBPs have been isolated from serum, amniotic fluid, and cell lines of various species, including porcine and rat vascular SMCs. 18 In view of the potential significance of PDGF/ IGF-I interactions, we aimed to establish how the various isoforms of PDGF influenced the expression of IGF-I, as well as the expression of IGFBP, since these may determine the eventual magnitude of the bioactivity of the endogenously produced IGF-I. We report that PDGF evokes a complex pattern of regulation of genes in the IGF/IGFBP system. They powerfully inhibit IGF-I production yet markedly induce biosynthesis of the inhibitory binding protein IGFBP-4. These data raise the possibility that PDGF may set in motion mechanisms to limit the final magnitude of the mitogenic response.
Materials and Methods Cell Culture
SMCs were isolated from rat thoracic aorta and cultured by a modification of the method of Chamley-Campbell et al,19 with minor modifications.20'21 Briefly, 27-45-day-old male Sprague-Dawley rats (Harlan Sprague Dawley, Inc., Indianapolis, Ind.) weighing 75-175 g were killed by CO2 asphyxia. A section of the aorta, from the aortic arch to the level of the renal arteries, was aseptically excised and placed in cold Hanks' balanced salt solution (HBSS, GIBCO, Grand Island, N.Y.). Adhering fat and connective tissue from the adventitia were stripped off by blunt dissection. Three to four vessels were extensively washed with fresh HBSS before being longitudinally opened. The opened aortas were dissociated in an enzymatic solution con-taining 0.1% collagenase (type CLS 2, 130 units/mg, Worthington Biochemical Corp., Freehold, N.J.), 0.05% elastase (Sigma Chemical Co., St. Louis, Mo.), 100 units/ml penicillin, and 100 gg/ml streptomycin (Irvine Scientific, Santa Ana, Calif.) for 15-20 minutes at 37°C in 95% air-5% CO2. The rest of the external connective tissue was then carefully removed under magnification, and the endothelial layer was scraped with a forceps. After dissection, aortas were placed in a fresh enzyme solution, minced into 1-2-mm pieces, and incubated in the above-mentioned conditions for an additional 1.5-2.0 hours. The suspension was triturated at 30-minute intervals. After the enzymatic disaggregation, the suspension was filtered through a nylon mesh and pelleted by centrifugation at 11Og for 10 minutes. Cells were resuspended with 8 ml Dulbecco's modified Eagle's medium (DMEM, Irvine Scientific). An aliquot of 100 gl was withdrawn, and cell viability was evaluated by trypan blue dye exclusion before inactivating the enzymes by addition of 1.98 ml fetal calf serum (FCS, Hyclone Laboratories, Inc., Logan, Utah). Flasks (75 cm2, Costar Corp., Cambridge, Mass.) were inoculated at a density of 2 x 104 viable cells/cm2. After approximately 2 weeks, the cells from the primary culture were harvested with a solution of trypsin (0.01%, Sigma) and collagenase (0.02%, Sigma) and plated at 2x104 cells/cm2. Subcultures were grown in DMEM supplemented with 10% FCS, 200 mM L-glutamine (Irvine Scientific), and antibiotics, with media changes three times weekly.
Cells were used between the third and seventh passages, in the subconfluent state. After being rinsed twice, cells were incubated with serum-free DMEM (Irvine Scientific) supplemented with L-glutamine (Irvine Scientific), 5 ,tg/ml transferrin, 0.2 mM ascorbate (Sigma), and antibiotics for 3 days. After this period of cellular synchronization, the medium was replaced with or without addition of the indicated concentrations of the mitogens for varying time intervals. Recombinant human PDGF-AA, -BB, and -AB (Bachem Inc., Torrance, Calif.) were dissolved in a vehicle of 10 mM acetic acid and 0.2% bovine serum albumin (BSA, Sigma) free of IGF-I and IGFBP. For the studies measuring radioimmunoassayable IGF-I and IGFBP by Western ligand blotting, cells were plated at 2x104 cells/cm2 onto six-well clusters and grown until subconfluent in DMEM with 10% FCS. After 3 days in serum-free medium, cells were incubated with PDGF isoforms as described above. At the indicated times, medium was collected, and cells were electronically counted (Coulter counter, Coulter Corp., Hialeah, Fla.). B104 rat neuroblastoma cells22 were obtained from D. Schubert IGF-II and rat IGF-II.24 A final dilution of 1:16,000 of the anti-human IGF-I antibody conferred 25-30% specific binding with [11"I]IGF-I (Amersham Corp., Arlington Heights, Ill.). Recombinant [Thr5"]human IGF-I (Amgen Biologicals, Thousand Oaks, Calif.) was used for standards. The minimal detectable dose was 2.0-3.0 pg. Conditioned media were cleared by centrifugation, and a 1-ml aliquot was acidified with 1 M acetic acid for 60 minutes before being submitted to ultrafiltration through an MPS-1 micropartition system (10,000-d cutoff, Amicon, Beverly, Mass.). Recovery of [1251]IGF-I added to conditioned media by this method was 85-93%. There was no detectable binding of the ultrafiltrate to [1251]IGF-I.
A second methodology to eliminate interference with binding proteins before radioimmunoassay was also used.25 This takes advantage of the ability of a large excess of IGF-II to displace IGF-I from binding sites on IGFBP. Because IGF-II is not recognized by the IGF-I antibody, this provides an alternative approach to eliminate binding protein artifacts, without exposing samples to acid ultrafiltration and consequently to variable rates of recovery. To this end, 125 ,l sample was preincubated for 30 minutes at room temperature with 125 gl human recombinant IGF-II (100 ng/ml) before assay.
Ligand Blots
Two milliliters of conditioned medium was concentrated 10 times by ultrafiltration through a centricon-10 microconcentrator (Amicon). A 75-,ul aliquot of the retentate was mixed with 25 gll sample buffer (62.5 mM Tris, 10% glycerol, 2.3% sodium dodecyl sulfate [SDS], and 10 mM dithiothreitol [pH 6.8]) and heated to 60°C for 10 minutes. Forty microliters of this mixture was loaded onto an 11% discontinuous SDS-polyacrylamide gel in nondenaturing conditions according to the method of Hossenlopp et al. 26 The samples were electrophoresed at a constant current of 15 mA for 3-4 hours or until 15 minutes after the dye front reached the bottom of the gel. Proteins were transferred in solution onto a 0.45-,uM nitrocellulose membrane (Trans-Blot transfer medium, Bio-Rad Laboratories, Richmond, Calif.) in a transfer cell at 200 mA for 40 minutes. The membrane was washed with 0.1% Tween-20 in saline for 1 hour and then with 1% BSA (IGF-I free) in 0.9 g% NaCl for 1 hour. The membrane was then incubated with [1251]IGF-I (200,000 cpm) in saline with 1% BSA and 0.1% Tween for 24 hours at 4°C. After hybridization, the membrane was washed with 0.9 g% NaCl with 1% BSA and 0. 1% Tween for three periods of 20 minutes each. Binding protein bands were visualized by autoradiography. The molecular weights were estimated by comparisons with 14C-labeled protein standards (Amersham), and densities of the bands were determined by scanning densitometry.
RNA Extraction
RNA was extracted from cells in culture by the method of Chirgwin et al. 27 Briefly, the medium was removed from each flask and stored at -70°C until further use. The cells were washed twice at 4°C with sterile 0.01 M phosphate-buffered saline, pH 7.5. A lysis solution (5 ml) containing 4 M guanidine isothiocyanate, 3 M sodium acetate (pH 6.0), 0.5% sodium N-lauroylsarcosine, and 0.83% 83-mercaptoethanol was added to each culture flask, and the cells were scraped with a rubber policeman. The suspension was homogenized with a glass tissue grinder for 5 minutes before being layered onto 4 ml of 5.7 M cesium chloride and centrifuged for 18-20 hours at 170,000g at 20°C. The supernatant was carefully removed, and the clear RNA pellet was resuspended with 0.3 M sodium acetate by repeated pipetting. The solubilized RNA was precipitated overnight with 2.5 vol ethanol at -20°C. The RNA was then pelleted, washed with 80% ethanol, dried, and resuspended in 10 mM Tris-HCl (pH 7.5) and 1 mM EDTA. UV spectrophotometry at 260 nM was used for quantitation of total RNA. The integrity and accuracy of the RNA quantitation were confirmed by submitting 5.0-,1tg aliquots of each sample to 1% agarose-formaldehyde gel electrophoresis and ethidium bromide staining. Only undegraded samples with intact 28S/18S ribosomal RNA and A260/A28, UV spectrophotometry ratios above 1.9 were processed.
Solution HybridizationiRNase Protection Assay
The probe used was provided by Drs. C.T. Roberts Jr. and D. LeRoith, National Institutes of Health, and contained a 322-bp fragment of rat IGF-I cDNA, cloned into a pGEM-2 vector that included 98 bp of the class A 5' untranslated region and 244 bp of the coding region corresponding to the prepeptide, B, C, and part of the A domains. 28, 29 For the experiments on regulation of IGF-I mRNA by cell density, RNA samples were cohybridized with both the IGF-I riboprobe and a rat f3-actin cRNA protecting 650 bases of the C-terminal and 3' untranslated region of the f,-actin mRNA transcript, which served as an internal control. For generation of antisense riboprobes, the linearized DNA template was transcribed and labeled in vitro with [`2PIUTP and T7 RNA polymerase according to a modification of the method of Melton et al. 30 Protection assays were performed as previously described.29,31 In short, 20-40 gg total RNA was resuspended in the hybridization buffer (20 mM Tris-HCl [pH 7.6], 1 mM EDTA, 0.4 M NaCl, 0.1% SDS, and 75% deionized formamide) containing 2-4 x 10' cpm labeled antisense RNA and incubated at 48°C for 16-18 hours. After hybridization, 270 ,ul RNase digestion buffer (10 mM Tris-HCl [pH 7.6], 5 mM EDTA, and 0.3 M NaCl) containing 40 ,ug/ml RNase A (Sigma) and 2 ,ug/ml RNase Ti (Pharmacia Fine Chemicals, Piscataway, N.J.) was added, and the mixture was incubated at 30°C for 60 minutes. SDS in a final concentration of 0.6% and 40 ,ug proteinase K (Sigma) were then added and incubated at 37°C for 15 minutes. Protected hybrids were precipitated by ethanol and size-separated on an 8% polyacrylamide/8 M urea denaturing gel. The gel was run at 45-50°C in 89 mM Tris-borate, 89 mM boric acid, and 2 mM EDTA for 5-6 hours. The gel was transferred to a solid support and exposed to x-ray film (RX-100, Fuji Photo Film Co., Ltd., Japan) with two intensifying screens (Quanta III, Du Pont Co., Wilmington, Del.). Laser scanning densitometry (soft laser scanning densitometer, Biomed Instruments Inc., Fullerton, Calif.) was used for quantitating RNA bands.
Northern Blots
For Northern blot analysis, gel electrophoresis of 20 gig total RNA was performed on 1% agarose gels containing 2.2 M formaldehyde, as previously described.32
The filters were hybridized in a buffer containing 50% formamide, 5x SSPE (43.8 g/l NaCl, 6.9 g/l NaH2PO4-H20, and 1.85 g/l EDTA), 5 x Denhardt's solution (1 g/l polyvinylpyrrolidone, 1 g/l BSA, and 1 g/l Ficoll 400), 0.1% SDS, and 200 ug/ml salmon sperm DNA for 48 hours at 42°C with 32P-labeled DNA probes. Probes were labeled with [a-32PIdCTP using the random-primer tech-nique33 following the manufacturer's protocol (Stratagene Inc., La Jolla, Calif.). The following rat probes were used: IGFBP-1, pRDBP, EcoRI-EcoRI fragment34; IGFBP-2, pRBP2 -501, EcoRI-HindIll fragment35; IGFBP-3, pRFI507, Apa I-Rso I fragment36; IGFBP-4, pRBP4-501, Sma I-HindlIl fragment37; and cyclophilin, pCD15.8.1, BamHI fragment.38
Results

Effects of Cell Confluence on IGF-I mRNA Content
The expression of growth factors can be affected by contact inhibition. To determine whether the degree of confluence of the cultures impacted on IGE-1 gene expression, SMCs were seeded at a density of 2x 104 cells/cm2 and allowed to grow for varying time periods in media containing 10% FCS. Cells were harvested at 4, 7, 9, 11, and 15 days after plating, and the RNA was extracted. Figure 1 shows an RNase protection assay in which total cellular RNA was cohybridized with the 5' untranslated IGF-I riboprobe and a rat f3-actin riboprobe, which was used as an internal control. Whereas IGF-I mRNA decreased as a function of cell confluence through 15 days in culture, /-actin mRNA remained constant, at least until day 11. The inhibitory effects of cell confluence on IGF-I gene expression are compatible with the data of Clemmons,12 who found an inverse relation between radioimmunoassayable IGF-I secretion and cell density in porcine SMCs. Because of these findings, most of the experiments described were performed in the subeonfluent state. Because the content of rat f3-actin mRNA was also regulated by serum (data not shown), this was not considered to be an appropriate internal control for studies of regulation of IGF-I mRNA. Samples were therefore standardized in parallel by running RNA aliquots on ethidium bromidestained minigels and visually confirming the accuracy of the RNA quantitation.
Effects of PDGF Isoforms on IGF-I Gene Expression
We determined the effects of the three PDGF isoforms, PDGF-AA, -BB, and -AEB, on SMC IGF-I mRNA content. Cells were deprived of serum for 72 hours before treatment with 20 ng/ml PDGF for the indicated times ( Figure 2 ). IGF-I mRNA abundance was markedly decreased by the three PDGF isoforms, an effect that was readily apparent at 4 hours and that persisted through 24 hours. Lane I corresponds to the protected fragments of 5' untranslated IGF-I mRNA from rat liver, which was used as a positive control (note that in contrast to SMCs, in which only the class C transcript is expressed, class A, B, and C IGF-I mRNA is expressed in the liver). The inhibitory effects of Days after plating 4 7 9 11 15 --FIGURE 1. Effects of cell confluence on insulin-like growth factor I mRNA content of vascular smooth muscle cells in vitro. A solution hybridizationiRNase protection assay of 40 gg smooth muscle cell RNA cohybridized with 5' untranslated insulin-like growth factor I riboprobe and a rat f3-actin riboprobe is shown. Cells were allowed to grow in 10% fetal calf serum for the indicated times after seeding (4-15 days). The upper arrow indicates protected 650-base /3-actin mRNA. The lower arrow indicates 241-base class C 5' untranslated insulin-like growth factor mRNA. as shown in Figure 3 . Decreased IGF-I mRNA abundance was apparent 4 hours after treatment with 20 ng/ml PDGF-AB and was more marked after 24 hours. There have been conflicting reports on regulation of IGF-I gene expression by PDGF.121416 One potential source of variability is the age of rats from which the primary SMC lines are derived. To examine this possibility, primary cultures were obtained from rats of three different ages, and the regulation of IGF-I expression was studied between the third and seventh passages. Table 1 summarizes data of experiments from five different cell lines. In all cell lines, PDGF isoforms decreased IGF-I mRNA content. Although there was some variability in the magnitude of the response, 20 ng/ml PDGF-AA, -BB, or -AB evoked a highly significant threefold to fivefold inhibition of IGF-I mRNA at 24 hours. The inhibitory effects of PDGF-AB on IGF-I mRNA content were dependent on protein synthesis, because they were completely abolished by pretreatment with 5 gg/ml cycloheximide (data not shown).
IGF-I was measured by radioimmunoassay from medium conditioned by SMCs that had been deprived of serum for 24, 48, or 72 hours ( Table 2) . IGF-I content in serum-free medium was very low and appeared to PDGF on IGF-I mRNA were concentration dependent, increase after prolonged serum deprivation. Treatment Smooth muscle cells contain solely class C protected bands. Cells were grown in serum-free medium for 72 hours and treated for the indicated times with serum-free medium alone (basal) or 20 ng/ml of either platelet-derived growth factor-AA, -BB, or -AB.
with even maximal concentrations of PDGF failed to increase IGF-I levels in the conditioned medium. Because IGF-I concentrations might have been affected by variable recovery rates after acid treatment and ultrafiltration, a subset of samples was assayed after the addition of excess amounts (100 ng/mI) of unlabeled recombinant IGF-II. In the absence of IGF-Il, IGF-I levels in the unfractionated samples were high, in all likelihood because of interference with IGF-binding proteins.25 After addition of IGF-II, radioimmunoassayable IGF-I content of conditioned medium was almost undetectable and not modified by addition of maximal concentrations of any of the PDGF isoforms (data not shown).
Production of IGF-Binding Proteins by Vascular SMCs
The production of IGF-binding proteins by SMCs was examined in serum-free conditioned media by Western ligand blotting with ['25I]IGF-I. Two IGFBPs of approximately 30 and 24 kd in size are present in SMCconditioned medium. As shown in Figure 4 , production of the 24-kd IGFBP increased as a function of cell confluence, whereas content of the 30-kd protein did not. As we will discuss below, the 24-kd IGFBP comigrates with IGFBP-4, which has been shown to be a powerful inhibitor of IGF-I action in bone cell cultures. Thus, in the confluent state, IGF-I biosynthesis is decreased, whereas production of the 24-kd IGFBP is enhanced; both would lead to lower IGF-I bioactivity FIGURE 3. Dose dependence ofplatelet-derived growth factor (PDGF) effects on smooth muscle cell insulin-like growth factor I mRNA content. Cells were grown in serum-free medium for 72 hours and then treated for 24 hours with the indicated concentrations of PDGF-AB. t-RNA indicates the riboprobe incubated with transfer RNA only. Liver contains class A (322 bases, upper arrow), B (297 bases, middle arrow), and C (241 bases, lower arrow) 5' untranslated alternative transcripts. and may explain in part the inhibition of growth observed in densely layered cells.
Regulation of IGFBP by PDGF Isoforms in Vascular SMCs
Vascular SMCs were depleted of serum for 72 hours and then treated with the indicated concentrations of either PDGF-BB ( Figure 5 , top panel), PDGF-AB (middle panel), or PDGF-AA (bottom panel) for 48 hours. All isoforms evoked a concentration-dependent increase in both 30-and 24-kd IGFBP. PDGF effects were far more marked, however, on the 24-kd protein.
Indeed, the increase in 30-kd IGFBP in response to 20 ng PDGF was approximately 40-60% at 48 hours. Because PDGF produced a comparable increase in SMC number at this time point (10-33%), it is likely that the perceived increase is not significant. The 24-kd IGFBP, however, increased by fivefold to sevenfold, an effect that clearly cannot be accounted for simply by the observed increase in cell number. As shown in the middle and bottom panels, the 24-kd IGFBP comigrated with a binding protein in the conditioned medium of the B104 neuroblastoma cell line, which has been identified as IGFBP-4. The PDGF isoforms are equipotent in their effect, as indicated in the middle and bottom panels, where conditioned media from cells treated with maximal concentrations of either PDGF-AB and -BB (middle panel) or PDGF-AA and -BB (bottom panel) were found to have almost identical levels of the JGFBPs. Finally, the effects of high concentrations of PDGF-AA and -BB were not additive. PDGF-stimulated IGFBP production accumulated in a time-dependent fashion for 48 hours, as shown in Figure 6 . The identity of the 30-kd IGFBP made by SMCs is unknown. IGFBP-4 is reported to be glycosylated in B104 cells. 39 To determine whether the 30-kd IGFBP was N-glycosylated, conditioned media from sparsely confluent cells (which release almost exclusively the 30-kd IGFBP) were incubated with N-glycanase before Western ligand blotting. As shown in Figure 7 , the 30-kd IGFBP was resistant to N-glycosylation, suggesting that it was not merely a glycosylated form of IGFBP-4.
The expression of IGFBP in SMCs was also examined by Northern gel electrophoresis. IGFBP-4 mRNA was expressed at a relatively low level in cells deprived of serum for 72 hours. Treatment of cells with maximal concentrations of PDGF-AB (20 ng/ml) markedly induced IGFBP-4 mRNA, with a peak at 4 hours ( Figure  8 ). The induction of IGFBP-4 mRNA was concentration dependent, as shown in Figure 9 . In contrast, expression of IGFBP-2 mRNA was clearly observed in serum-deprived cells and appeared to be slightly decreased by PDGF. Quiescent or PDGF-stimulated SMCs did not express IGFBP-1 or IGFBP-3 mRNA (not shown).
Discussion
Vascular SMCs provide structure and elasticity to the blood vessel. In their differentiated "contractile" state, Cells were deprived of serum for either 24, 48, or 72 hours and treated with or without the indicated concentrations of the respective PDGF isoforms fOr a further 24 hours.
they lie embedded in the medial layer of the arterial wall, where they constitute the only cell type. When subjected to appropriate stimuli, a subpopulation of medial SMCs develops the ability to migrate and also regains the capacity to proliferate. This phenotypical dedifferentiation is a common factor underlying the pathogenesis of the atherosclerotic plaque and in the events occurring during vascular regeneration after balloon angioplasty.4''41 Besides passively responding to exogenous stimuli, it is now clear that vascular SMCs can also generate locally acting cytokines and matrix proteins, which contribute to the milieu in which growth and differentiated properties are regulated and synchronized.
PDGF has been implicated as a major cytokine in this process. PDGF alone, however, is a relatively weak mitogen. To complete DNA synthesis, mesenchymal cells require the presence of "progression factors," such as IGF-I and epidermal growth factor.42 IGF-I is abundantly present in serum, where it circulates complexed to various IGF-binding proteins. Additionally, IGF-I is also produced by many tissues and cells, including arteries,13 and by their main cell type, the SMCs of the tunica media.4344 As IGF-I synergizes with PDGF to promote SMC growth, it has been postulated that local expression of IGF-I within the vessel wall may be an important determinant of this process. The observation that IGF-I mRNA is markedly induced in the rat aorta after balloon denudation'3 indicates that expression of 24 h 4 IGF-I may be responsive to locally acting stimuli. A candidate regulatory factor is PDGF itself, which can gain access to the injured SMCs of the arterial media from a number of sources. Besides being present in platelets, isoforms of PDGF are also produced by infiltrating macrophages (PDGF-BB)6 and by vascular SMCs themselves (PDGF-AA).7,8 There is evidence that PDGF isoforms may differ in their bioactivity:
PDGF-AB and -BB stimulate chemotaxis of fibroblasts, whereas PDGF-AA does not. 45 The PDGF B chain exhibits 10-100-fold greater transforming efficiency in the NIH 3T3 cell transformation assay than does PDGF A. 46 Thus, when examining the effects of PDGF, it is important to determine the effects of all isoforms, particularly in the case of SMCs, which may be exposed to all of these in different physiological or pathological conditions.
As in aortic tissue,'3 we observed that vascular SMCs contain primarily the class C 5' untranslated IGF-L mRNA transcript. This tissue-specific splicing involving the 5' untranslated region is compatible with what has been previously described for other nonhepatic tissues. 28 In contrast, liver contains the three major 5' untranslated alternative transcripts, classes A, B, and C.
There has been speculation that transcripts containing different 5' untranslated regions may be subject to tissue-specific translational regulation, although this remains to be proven. In contrast, the relative content of the 3' untranslated splicing variant IGF-I mRNAs in SMCs is identical to that in the liver (data not shown) and aorta. '3 Perhaps paradoxically, we found that all PDGF isoforms evoked marked inhibition of IGF-I mRNA content of vascular SMCs that had been deprived of serum for 72 hours. The inhibition was significant after 4 hours and reached 20-35% of control levels after 24 hours.
The inhibitory effects were observed in cell lines derived from rats of three different ages. This is in agreement with the data of Bornfeldt et al, '6 who reported that IGF-I mRNA content of rat vascular SMCs was inhibited by newborn calf serum, PDGF, and basic fibroblast growth factor, with a very similar time course to that described above. IGF-I mRNA content of rat fibroblasts is inhibited by serum, an effect that is dependent on new protein synthesis. 47 We also ob-48 h FIGURE 6. Time course of insulin-like growth factor binding protein accumulation in smooth muscle cell-conditioned medium after addition ofplatelet-derived growth factor (PDGF) BB (10 ng/ml) to serum-deprived cultures. Control, serum-free medium alone. served that PDGF inhibition of IGF-I mRNA was prevented by cycloheximide, a protein synthesis inhibitor. In contrast to these findings, Delafontaine et al'4 observed a twofold to threefold induction of IGF-I mRNA in vascular SMCs by PDGF. The reason for this discrepancy is not immediately apparent. Our studies were performed after more prolonged serum deprivation (72 versus 48 hours). Perhaps more significantly, phenotypic properties of vascular SMCs are subject to considerable variability. 48 As documented in this article, however, we studied five independently derived SMC lines, all of which exhibited marked inhibition of IGF-1 mRNA levels after 24 hours. We also found that SMC IGF-I mRNA content decreased as a function of cell confluence. Clemmons and Shaw49 reported that basal somatomedin production by human fibroblasts from subjects of different ages was consistently less in dense than in sparse cultures.
Our data indicate that these findings are also valid for vascular SMCs. Interestingly, as will be discussed below, production of the 24-kd IGF-binding protein increased as a function of cell confluence. It is conceivable that decreased IGF-I expression and bioactivity may contribute to the refractoriness to growth stimulation observed in densely layered cultures of SMCs.
We found that serum-free SMC-conditioned medium contained low but detectable amounts of radioimmunoassayable IGF-I. Treatment of cells with PDGF did not significantly modulate radioimmunoassayable IGF-I concentrations. It is clear, however, that any inhibition would not have been detected, because levels would be * 9 w cyclophilin FIGURE 8 . Time course of regulation of insulin-like growth factor binding protein 4 (BP4) and insulin-like growth factor binding protein 2 (BP2) mRNA by platelet-derived growth factor-AB (PDGF-AB). Cells were incubated in serum-free medium for 72 hours and then treated for the indicated times with 20 ng/ml PDGF-AB. Blot was sequentially hybridized with insulin-like growth factor BP4 cDNA (top panel), insulin-like growth factor BP2 cDNA (middle panel), and cyclophilin cDNA (bottom panel).
below the sensitivity of the assay. Clemmons previously reported that purified PDGF stimulated radioimmunoassayable IGF-I production from porcine aortic SMCs12 and cultured human fibroblasts. 15 A trivial explanation for these conflicting data is that the SMCs originated from different animal species. It is likely, however, that a fundamental mechanism possibly involved in tissue repair will be phylogenetically conserved. There are significant differences in the methodologies used to remove interfering binding proteins from conditioned media in the above-referenced stud-iesl516A49 and that reported here. Clemmons separated IGF-I from IGF binding proteins by acidification and assayed the samples after lyophilization and reconstitution in phosphate-buffered saline at neutral pH. There have subsequently been several reports that document that acidification alone or acid-ethanol precipitation does not efficiently eliminate interference with binding proteins, particularly in samples of conditioned medium in which amounts of IGF-I are low.23 Therefore, we assayed our acidified conditioned medium samples after filtration through a micropartition system with a 10,000-d cutoff. Effective removal of IGFBP was confirmed by lack of binding of [1251]IGF-I to the ultrafiltrate. Because filtration procedures can be affected by variable recovery rates, we also assayed samples after preincubation with excess IGF-II, which saturates binding sites on IGFBP and frees IGF-I for interaction with the specific polyclonal antibody. Using either of these techniques, we were unable to demonstrate regulation of radioimmunoassayable IGF-I by PDGF. Furthermore, as will be discussed below, PDGF selectively stimulates production of a 24-kd IGFBP, which in all likelihood is IGFBP-4. Mohan et a12 have shown that IGFBP-4 interferes in the IGF-I radioimmunoassay in a concentration-dependent fashion. It is thus conceivable that reported increases in IGF-I production by SMCs in response to PDGF may indeed reflect stimulation of IGFBP-4 release by these cells. There is also indirect evidence suggesting that PDGF may not be a significant stimulus for IGF-I production in vascular SMCs. After balloon injury, aortic IGF-I mRNA is induced with a peak at 7 days after the procedure.13 In contrast, platelets adhere to the denuded vascular surface within minutes, and local PDGF-AA expression by SMCs occurs within 24 hours of injury.7 The timing of IGF-I gene overexpression by vascular cells in vivo is thus far removed from that of PDGF and suggests that other agents must be involved in the process.
Vascular SMCs contain abundant receptors for IGF-I. The bioactivity of IGF-I, however, is also dependent on the presence of IGF binding proteins in the extracellular environment, which can potentially either inhibit or augment IGF-I action, depending on the kind of IGFBP and the characteristics of the target cell. McCusker et all" reported the presence of two IGFBPs of 31 and 24 kd in porcine vascular SMCs. We have identified two proteins of similar size in rat SMCconditioned medium. Interestingly, release of the 24-kd but not the 30-kd IGFBP was increased as a function of cell confluence. Before our studies, there were, to our knowledge, no data on regulation of IGFBP in vascular SMCs. We observed that PDGF isoforms stimulated production of the 24-kd IGFBP in a concentrationand time-dependent fashion. The 24-kd IGFBP was found to comigrate with IGFBP-4. The amino acid composition and cDNA sequence for IGFBP-4 have been reported for both human and rat.5Ys5 1 Accordingly, PDGF was found to induce IGFBP-4 mRNA content of serum-deprived SMCs. IGFBP-4 is abundantly released into the culture medium by TE-39 osteoblast-like human osteosarcoma cells and by normal human osteoblasts.52 When added to bone cells in basal serum-free conditions, IGFBP-4 inhibits bone cell proliferation by 40%, probably by antagonizing the biological activity of endogenously produced IGF. However, IGFBPs may have intrinsic biological activity independent of their ability to bind to IGFs, as has recently been reported for an IGFBP from vascular endothelial cells.53 PDGF effects on IGFBP production are not a feature common to all mesenchymal cells, since no increase in IGFbinding activity of human fibroblast-conditioned medium was observed after treatment of PDGF for up to 48 hours. 54 Finally, although the identity of the 30-kd protein is not known, it does not appear to be a glycosylated form of IGFBP-4, since the migration of this protein was not affected by digestion with N-glycanase (and IGFBP-4 has no 0-linked glycosylation). SMCs expressed IGFBP-2 mRNA, which codes for an approximately 30-kd protein and probably corresponds to the protein of similar size observed in the Western ligand blots. There was no evidence of expression of IGFBP-1 or IGFBP-3 mRNA by SMCs. The mechanisms of PDGF stimulation of DNA synthesis and cell proliferation have been extensively studied.55 a-PDGF and f-PDGF receptors share considerable structural similarity and contain tyrosine kinase domains. A number of cellular responses ensue within minutes of PDGF binding: activation of the receptor tyrosine kinase, phosphatidylinositol hydrolysis, phosphorylation of GTPase-activating protein (with consequent activation of the ras mitogenic pathway),56 adenylate cyclase activation, alterations in cellular pH and cytosolic calcium, receptor internalization, and expression of a group of "early response genes" (reviewed in Reference 55). PDGF also promotes expression of the "intermediate response genes" JE and KC,5758 which apparently function as paracrine cytokines. We propose that PDGF induction of IGFBP biosynthesis may serve to modulate IGF-I responsiveness, perhaps by targeting the growth factor to certain tissue compartments and/or by antagonizing IGF-I action and thus limiting the final magnitude of the stimulus for cell division.
